Nearly one in five civil monetary penalty settlements related to Emergency Medical Treatment and Labor Act (EMTALA) violations involved psychiatric emergencies. That is the conclusion of a study to be published in the May ...
May 13, 2019
0
1
Twenty years after reaching a landmark legal settlement with the tobacco companies, the states continue to spend only a small fraction of their billions in tobacco revenue on programs to prevent kids from using tobacco and ...
Dec 16, 2018
0
60
More than 400 cases against opioid manufacturers, distributors, and pharmacies are pending before a single federal judge, with the potential to net billions to address the crisis. But winning those suits would only be the ...
Mar 27, 2018
0
1
EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...
Aug 17, 2017
0
0
Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.
May 24, 2017
0
0
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
The maker of a prescription fish-oil drug says it has reached a legal settlement that will allow it to promote unapproved uses of its drug for lowering fat levels.
Mar 8, 2016
0
1
Federal officials are ordering the recall of nearly 2,800 machines used to disinfect medical scopes. They blamed company violations that could lead to infections in patients.
Nov 13, 2015
0
11
The Justice Department said Friday that it had reached settlements totaling more than $250 million with hundreds of hospitals where doctors implanted cardiac devices in violation of Medicare coverage requirements.
Oct 31, 2015
0
19
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10
